RE:RE:RE:RE:RE:88% demonstrate that CR at 180 days, 69% at 270 days Heye gang, still hanging in here, did some travel in Europe recently for a spring break .
Yes, agree with results being promising, but the point below needed to be clarified. thanks FGP .
Good news is that the Total of CR and PR at 360 is 39% , which is a healthy number . The possibilty exists for some of the PR group to become CR . See here :
3 Partial Response (“PR”) is defined as patients who display either positive cystoscopy and negative urine cytology or negative cystoscopy and positive urine cytology during an assessment visit. According to the FDA guidance, patients participating in Study II, who are currently diagnosed as PR, may be re-classified as CR, if the cystoscopy is positive, low grade NMIBC is detected and the urine cytology is negative or if urine cytology is positive, cystoscopy is negative and upper tract or prostatic urethra urothelial cell carcinoma is detected. Coop
FGPstock wrote:
I think you guys may be reading this statement wrong. 46% were CR after 90 days. then 88% of the 46% were still CR after 180.
Not sure how the PR factors in
For all Evaluable Patients, who achieved a CR at 90 days, 88% demonstrate that CR at 180 days, 69% at 270 days, 50% at 360 days and 56% at 450 days, demonstrating a strong duration of complete response.